Showing 31-40 of 542 results for "".
Dysregulation of Type 2 Immune Pathway
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/dysregulation-of-type-2-immune-pathway/48788/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses the role of type 2 inflammatory response in immune dysregulation in atopic dermatitis.SCALE 2024: Dr. Joel Cohen Interviews Dr. Saranya Wyles on Exosomes
https://practicaldermatology.com/conferences/scale-2024/scale-2024-dr-joel-cohen-interviews-dr-saranya-wyles-exosomes/26364/Saranya Wyles, MD, PhD, joins Joel Cohen, MD, to discuss her research on exosomes at Music City SCALE.Connections for the Future of Dermatology
https://practicaldermatology.com/series/skin-minute/connections-for-the-future-of-dermatology/54688/Frederick Beddingfield, MD, PhD, recaps the Dermatology Summit 2026, a meeting to connect innovators and investors in the field of dermatology.IL-31’s Role in Prurigo Nodularis
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/il-31s-role-in-prurigo-nodularis/48804/Raj Chovatiya, MD, PhD, MSCI, FAAD, explains the role of the IL-31 pathway in neuroinflammatory disease such as prurigo nodularis.Navigating the Latest Therapeutic Options
https://practicaldermatology.com/issues/october-2025/navigating-the-latest-therapeutic-options/39762/A Q&A With Raj Chovatiya, MD, PhD, MSCI, FAADPD Asks: What would your staff say is the one thing you do that most aggravates them?
https://practicaldermatology.com/topics/practice-management/pd-asks-what-would-your-staff-say-is-the-one-thing-you-do-that-most-aggravates-them/19695/John E. Harris, MD, PhD explains why his frequent travel might leave his staff feeling a bit annoyed at times!Noah Worcester 2024: Dr. Mesinkovska on Alopecia Areata
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-mesinkovska-alopecia-areata/24586/Natasha Atanaskova Mesinkovska. MD, PhD, summarizes her lecture on JAK inhibitors and minoxidil at the 2024 Noah Worcester Dermatological Society meeting.Psoriasis 2020
https://practicaldermatology.com/topics/psoriasis/psoriasis-2020/19720/Bruce Strober, MD, PhD reviews the latest advances in psoriasis therapy, including anticipated breakthroughs in biologics, small molecule agents, and topicals.What's New in Atopic Dermatitis?
https://reachmd.com/programs/practical-dermatology/whats-new-in-atopic-dermatitis/33014/Emma Guttman, MD, PhD, professor and chair of dermatology at Mount Sinai, talks about the latest developments in treatments and therapies for atopic dermatitis.Sleep Disturbances and Psychological Burden of Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/sleep-disturbances-and-psychological-burden-of-prurigo-nodularis/37182/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses the impact of itch from prurigo nodularis on quality of life through sleep disturbances and mental health effects.